This finding also demonstrates that specific small-molecule inhibitors targeting the ADAR1 pathway can effectively block the self-renewal and stemness of GSCs, thus suggesting a potential therapeutic strategy for glioblastoma. The gene discussed is ADAR; the disease is glioblastoma.